血必净药氧吸入方式给药治疗慢性肺心病急性期效果探讨  

Xuebijing Medicine Oxygen Inhalation of Chronic Pulmonary Heart Disease and Outcome of Drug Treatment

作　　者：陈建军[1] 

机构地区：[1]如皋市人民医院ICU,江苏如皋226500

出　　处：《中外医疗》2015年第20期140-141,共2页China & Foreign Medical Treatment

摘　　要：目的分析血必净药氧吸入方式给药治疗慢性肺心病急性期患者的临床效果。方法随机抽选2014年1月—2015年1月,该院接收慢性肺心病急性期患者30例(医治组),选择同期接收患者30例作为对照组,对照组患者给予临床基础性治疗,医治组患者在基础治疗上加血必净药物,比对两组患者临床治疗效果。结果医治组患者临床好转率(93.3%)和对照组(73.3%)相比,差异具有统计学意义(P<0.05);且医治组患者临床症状、并发症总率(6.7%)和对照组(30.0%)相比,差异具有统计学意义(P<0.05)。结论给予慢性肺心病急性期患者临床血必净药氧吸入治疗,安全性高,可改善患者临床症状,提高好转率,意义重大,值得使用。Objective To analysis the clinical effect of drug administered Xuebijing oxygen inhalation therapy in patients with acute exacerbation of chronic pulmonary heart disease. Methods From January 2014 to January 2015,30 patients in our hospital receiving chronic pulmonary heart disease in acute stage patients（treatment group）, while receiving patients 30 cases as control group, patients in the control group were given clinical treatment group basic treatment plus Xuebijing drugs on the basis of the treatment, then compare the clinical curative effect between two groups. Results The treatment group of patients with clinical improvement rate was 93.3% while the control group was 73.3%,there were remarkable difference between them（P〈0.05）; Further more, the clinical symptoms and complication rate between treatment group and control group were evidently different（P〈0.05）,they were 6.7% and 30.0% Respectively. Conclusion Clinical medicine given Xuebijing injection in patients with chronic pulmonary heart disease in acute stage of oxygen inhalation therapy is worth using. Because its high security and can improve the clinical symptoms,fureher more,it can improve the recovery rate significantly.

关 键 词：血必净药氧吸入 慢性肺心病急性期 临床效果 

分 类 号：R259[医药卫生—中西医结合]